<DOC>
	<DOCNO>NCT00113854</DOCNO>
	<brief_summary>Cerebral malaria life-threatening complication Plasmodium falciparum infection African child nonimmune traveller despite availability quinine , current drug choice . Several report suggest raise intracranial pressure ( ICP ) major cause death among child cerebral malaria . Mannitol , osmotic diuretic , effectively lower ICP use treat post traumatic raise ICP . There case report reduction mortality morbidity African child cerebral malaria follow administration mannitol , randomize control trial difficult evaluate significance . This study seek establish whether single dose intravenous mannitol give child cerebral malaria significantly reduce coma recovery time .</brief_summary>
	<brief_title>Mannitol Adjunct Therapy Childhood Cerebral Malaria</brief_title>
	<detailed_description>Cerebral malaria life-threatening complication Plasmodium falciparum infection accounting significant morbidity mortality African child despite availability quinine , current drug choice . The case fatality range 5 40 % almost 10 % survivor experience neurological sequela . Several report suggest raise intracranial pressure ( ICP ) may feature cerebral malaria . There evidence brain swell computer tomography , magnetic resonance imaging necropsy . It postulate raise intracranial pressure cause death transtentorial herniation compromise cerebral blood flow . In fact , child die cerebral malaria Kenyan study , clinical sign compatible transtentorial herniation severe ICP ( maximum ICP &gt; 40mmHg ) either die survived neurological sequela . Mannitol , osmotic diuretic , effectively lower ICP use treat post traumatic raise intracranial pressure . There case report reduction mortality morbidity African child cerebral malaria follow administration mannitol , randomize control trial difficult evaluate significance . Currently WHO contend insufficient evidence use mannitol adjunct therapy cerebral malaria . A recent Cochrane review find randomized quasi-randomized control trial support refute use mannitol adjunct therapy cerebral malaria . Hypothesis : A single dose intravenous mannitol ( 1g/kg ) give child cerebral malaria reduce mean coma recovery time 22.5 13.1 hour . We calculate sample size 78 patient group 90 % power 95 % confidence . In calculation , assume child receive intravenous mannitol would mean coma recovery time 13.1 ( SD 18.5 ) hour receive placebo would mean coma recovery time 22.5 ( SD 18.5 ) hour ( 42.3 % effect size ) , accord recent study Aceng , Byarugaba Tumwine hospital .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Cerebral</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Children age 6 month 5 year admit Mulago hospital acute care unit study period cerebral malaria : ( seizure unarousable coma last 30 minute seizure stop , asexual form P. falciparum blood film , cause coma ) whose carers give inform consent . Children evidence receive sedation within two hour prior admission acute care unit . Also exclude child clinical sign pulmonary congestion , heart failure , renal disease , shock</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>cerebral</keyword>
	<keyword>malaria</keyword>
	<keyword>child</keyword>
	<keyword>mannitol</keyword>
	<keyword>adjunct</keyword>
	<keyword>therapy</keyword>
	<keyword>Uganda</keyword>
</DOC>